当前位置:首页 - 行情中心 - 迈普医学(301033) - 财务分析 - 现金流量表

迈普医学

(301033)

  

流通市值:38.94亿  总市值:46.23亿
流通股本:5646.91万   总股本:6704.96万

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金279,703,271.51183,049,028.0280,556,137.62304,523,588.74
  收到的税费返还342,635.58338,924.9-3,481,891.98
  收到其他与经营活动有关的现金5,835,349.972,442,205.2812,465,768.7333,047,736.14
  经营活动现金流入小计285,881,257.06185,830,158.293,021,906.35341,053,216.86
  购买商品、接受劳务支付的现金35,573,601.3219,733,698.597,641,759.249,544,801.28
  支付给职工以及为职工支付的现金68,917,119.3347,411,634.5227,616,516.7772,614,589.44
  支付的各项税费34,060,786.8124,736,660.9912,591,901.7242,181,158.36
  支付其他与经营活动有关的现金63,571,561.0437,427,210.815,966,981.6360,328,314.79
  经营活动现金流出小计202,123,068.5129,309,204.963,817,159.32224,668,863.87
  经营活动产生的现金流量净额83,758,188.5656,520,953.329,204,747.03116,384,352.99
二、投资活动产生的现金流量:
  收回投资收到的现金475,217,471.23344,892,252.41164,034,454.41436,499,839.26
  取得投资收益收到的现金-14,650-24,8502,100-
  处置固定资产、无形资产和其他长期资产收回的现金净额50,766.9250,766.9265030,150.34
  投资活动现金流入小计475,253,588.15344,918,169.33164,037,204.41436,529,989.6
  购建固定资产、无形资产和其他长期资产支付的现金17,915,776.239,566,325.414,504,502.2233,162,998.17
  投资支付的现金524,985,192375,654,794217,319,275411,696,920
  投资活动现金流出小计542,900,968.23385,221,119.41221,823,777.22444,859,918.17
  投资活动产生的现金流量净额-67,647,380.08-40,302,950.08-57,786,572.81-8,329,928.57
三、筹资活动产生的现金流量:
  吸收投资收到的现金12,955,659.6--9,312,192
  筹资活动现金流入平衡项目0--0
  筹资活动现金流入小计12,955,659.6--9,312,192
  偿还债务支付的现金---50,299,348.44
  分配股利、利润或偿付利息支付的现金39,696,972.9139,696,972.91-27,135,621.19
  支付其他与筹资活动有关的现金956,920.1791,169.8510,502.213,546,790.47
  筹资活动现金流出小计40,653,893.0140,488,142.71510,502.290,981,760.1
  筹资活动产生的现金流量净额-27,698,233.41-40,488,142.71-510,502.2-81,669,568.1
四、汇率变动对现金及现金等价物的影响476,542.53495,324.34169,295.21156,134.77
五、现金及现金等价物净增加额-11,110,882.4-23,774,815.15-28,923,032.7726,540,991.09
  加:期初现金及现金等价物余额53,217,601.2753,217,601.2753,217,601.2726,676,610.18
  期末现金及现金等价物余额42,106,718.8729,442,786.1224,294,568.553,217,601.27
补充资料:
  净利润-47,299,142.7-78,854,230.23
  资产减值准备--23,067.44-165,805.78
  固定资产和投资性房地产折旧-9,387,949.9-18,722,100.68
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-9,387,949.9-18,722,100.68
  无形资产摊销-4,007,817.59-6,981,866.89
  长期待摊费用摊销-381,918.21-786,620.57
  处置固定资产、无形资产和其他长期资产的损失----790.78
  固定资产报废损失-2,106,750.41-483,413.21
  公允价值变动损失-446,766.21--151,575.36
  财务费用--1,374,104.05--1,228,423.41
  投资损失--1,785,129.36--3,428,431.47
  递延所得税--411,822.16--3,012,035.52
  其中:递延所得税资产减少--69,354.19--3,046,522.23
    递延所得税负债增加--342,467.97-34,486.71
  存货的减少--3,696,398.97--8,148,118.89
  经营性应收项目的减少-7,005,958.55--4,426,627.74
  经营性应付项目的增加--7,484,739.1-16,182,389.43
  其他---13,181,143.62
  现金的期末余额-29,442,786.12-53,217,601.27
  减:现金的期初余额-53,217,601.27-26,676,610.18
  现金及现金等价物的净增加额--23,774,815.15-26,540,991.09
公告日期2025-10-242025-08-222025-04-252025-04-25
审计意见(境内)标准无保留意见
TOP↑